Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,495,139
+$801,133 QoQ
Shares Held
2,914
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.97%
of 13F equity value
Holder Rank
#1,999
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NCM Capital Management, LLC holds $13,457,736 across 8 Drug Manufacturers - General names. LLY ranks #1 (26.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,914 | $3,495,139 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,441 | $2,369,668 | |
| 3 | ABBV |
AbbVie Inc.
|
7,769 | $1,954,991 | |
| 4 | JNJ |
Johnson & Johnson
|
6,049 | $1,536,264 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,901 | $1,250,892 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,722 | $1,078,761 | |
| 7 | PFE |
Pfizer Inc
|
38,580 | $929,006 | |
| 8 | AMGN |
Amgen Inc
|
2,328 | $843,015 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,495,139 | 2,914 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,694,006 | 2,929 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,334,732 | 3,103 | Shares | Sole | 2026-03-02 | |
| 2025-09-30 | $2,474,409 | 3,243 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,309,747 | 2,963 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,453,778 | 2,971 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,150,792 | 2,786 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,798,458 | 2,030 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,837,921 | 2,030 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,657,054 | 2,130 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,241,619 | 2,130 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,142,475 | 2,127 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,039,259 | 2,216 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $773,381 | 2,252 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $823,871 | 2,252 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $728,184 | 2,252 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $730,165 | 2,252 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $620,277 | 2,166 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $598,016 | 2,165 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||